SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-244726
Filing Date
2021-08-12
Accepted
2021-08-12 16:23:26
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d165555d10q.htm   iXBRL 10-Q 1858593
2 EX-10.1 d165555dex101.htm EX-10.1 25642
3 EX-10.2 d165555dex102.htm EX-10.2 93517
4 EX-10.3 d165555dex103.htm EX-10.3 93763
5 EX-31.1 d165555dex311.htm EX-31.1 7243
6 EX-31.2 d165555dex312.htm EX-31.2 7203
7 EX-32.1 d165555dex321.htm EX-32.1 5858
  Complete submission text file 0001193125-21-244726.txt   6922241

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20210729.xsd EX-101.SCH 50266
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ymtx-20210729_cal.xml EX-101.CAL 53094
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ymtx-20210729_def.xml EX-101.DEF 227388
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20210729_lab.xml EX-101.LAB 447864
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20210729_pre.xml EX-101.PRE 341479
13 EXTRACTED XBRL INSTANCE DOCUMENT d165555d10q_htm.xml XML 876657
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 211167920
SIC: 2834 Pharmaceutical Preparations